Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

H. Gallion · SciRah

Researcher profile · Semantic Scholar

H. Gallion

Share profile

H. Gallion — researcher profile on SciRah

h-index: 42
Works: 159
Citations: 5,372

Most-cited papers

The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer.
J. van Nagell, P. Depriest, Mark Reedy, H. Gallion +3 more
2000Gynecologic Oncology330 citations
Semantic Scholar
Ovarian volume related to age.
E. Pavlik, P. Depriest, H. Gallion, F. Ueland +3 more
2000Gynecologic Oncology294 citations
Semantic Scholar
A morphology index based on sonographic findings in ovarian cancer.
P. Depriest, D. Shenson, A. Fried, J. Hunter +5 more
1993Gynecologic Oncology229 citations
Semantic Scholar
Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer.
M. Thrall, J. Deloia, H. Gallion, N. Avril
2007Gynecologic Oncology190 citations
Semantic Scholar
The malignant potential of small cystic ovarian tumors in women over 50 years of age.
C. Bailey, F. Ueland, G. Land, P. Depriest +3 more
1998Gynecologic Oncology178 citations
Semantic Scholar
Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study.
G. Sutton, J. Kauderer, L. Carson, S. Lentz +2 more
2005Gynecologic Oncology128 citations
Semantic Scholar
Transvaginal sonography as a screening method for the detection of early ovarian cancer.
P. Depriest, H. Gallion, E. Pavlik, R. Kryscio +1 more
1997Gynecologic Oncology112 citations
Semantic Scholar
Randomized phase III trial of standard timed doxorubicin plus cisplatin versus circadian timed doxorubicin plus cisplatin in stage III and IV or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study.
H. Gallion, V. L. Brunetto, M. Cibull, S. Lentz +4 more
2003Journal of Clinical Oncology111 citations
Semantic Scholar
Endometrioid carcinoma of the ovary and endometriosis: the association in postmenopausal women.
P. Depriest, E. R. Banks, D. Powell, J. van Nagell +5 more
1992Gynecologic Oncology110 citations
Semantic Scholar
Racial disparity in survival among patients with advanced/recurrent endometrial adenocarcinoma
G. L. Maxwell, C. Tian, J. Risinger, C. Brown +5 more
2006Cancer105 citations Open access
Semantic Scholar
Familial site-specific ovarian cancer is linked to BRCA1 on 17q12-21.
E. Steichen-Gersdorf, H. Gallion, D. Ford, C. Girodet +6 more
1994American Journal of Human Genetics92 citations
Semantic Scholar
Lymph node metastases and prognosis in patients with stage IA2 cervical cancer.
S. Buckley, D. Tritz, L. Van Le, R. Higgins +9 more
1996Gynecologic Oncology90 citations Open access
Semantic Scholar
Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group study
C. Tian, C. Ambrosone, K. Darcy, T. Krivak +7 more
2011Gynecologic Oncology88 citations Open access
Semantic Scholar
CA125- and tumor-specific T-cell responses correlate with prolonged survival in oregovomab-treated recurrent ovarian cancer patients.
A. Gordon, B. Schultes, H. Gallion, R. Edwards +3 more
2004Gynecologic Oncology84 citations
Semantic Scholar
Progression‐free interval in ovarian cancer and predictive value of an ex vivo chemoresponse assay
H. Gallion, W. Christopherson, R. Coleman, L. DeMars +5 more
2004International Journal of Gynecologic Cancer83 citations Open access
Semantic Scholar
Genetic alterations distinguish different types of ovarian tumors
M. Pieretti, C. Cavalieri, P. S. Conway, H. Gallion +2 more
1995International Journal of Cancer79 citations
Semantic Scholar
Loss of heterozygosity and genomic instability in synchronous endometrioid tumors of the ovary and endometrium
David L. Shenson, H. Gallion, D. Powell, M. Pieretti
1995Cancer75 citations Open access
Semantic Scholar
Relationship Between ERCC1 Polymorphisms, Disease Progression, and Survival in the Gynecologic Oncology Group Phase III Trial of Intraperitoneal Versus Intravenous Cisplatin and Paclitaxel for Stage III Epithelial Ovarian Cancer
T. Krivak, K. Darcy, C. Tian, D. Armstrong +4 more
2008Journal of Clinical Oncology73 citations Open access
Semantic Scholar
High-resolution methylation analysis of the BRCA1 promoter in ovarian tumors.
Cathy B. Wilcox, B. Baysal, H. Gallion, Mary Strange +1 more
2005Cancer Genetics and Cytogenetics67 citations
Semantic Scholar
Centrosome abnormalities in ovarian cancer
Lih-Ching Hsu, M. Kapali, J. Deloia, H. Gallion
2005International Journal of Cancer63 citations Open access
Semantic Scholar
Impact of body mass index on treatment outcomes in endometrial cancer patients receiving doxorubicin and cisplatin: a Gynecologic Oncology Group study.
S. Modesitt, C. Tian, R. Kryscio, J. Thigpen +3 more
2007Gynecologic Oncology62 citations
Semantic Scholar
Resistance to tamoxifen with persisting sensitivity to estrogen: possible mediation by excessive antiestrogen binding site activity.
E. Pavlik, K. Nelson, Suseela Srinivasan, D. Powell +4 more
1992Cancer Research60 citations
Semantic Scholar
The molecular basis of ovarian cancer
H. Gallion, M. Pieretti, P. Depriest, J. R. van Nagell
1995Cancer58 citations
Semantic Scholar
Genetic alterations on chromosome 17 distinguish different types of epithelial ovarian tumors.
M. Pieretti, D. Powell, H. Gallion, E. A. Case +2 more
1995Human Pathology55 citations
Semantic Scholar
Ovarian Cancer Screening in Asymptomatic Postmenopausal Women
P. Depriest, J. van Nagell, H. Gallion, D. Shenson +4 more
199351 citations
Semantic Scholar
Clinical Assessment of 111In-CYT-103 Immunoscintigraphy in Ovarian Cancer
E. Surwit, J. Childers, D. Krag, J. Katterhagen +3 more
199343 citations
Semantic Scholar
Therapeutic implications of lymph nodal spread in lateral T1 and T2 squamous cell carcinoma of the vulva.
S. J. Andrews, Bryn T. Williams, P. Depriest, H. Gallion +4 more
1994Gynecologic Oncology42 citations
Semantic Scholar
Ovarian cancer screening in asymptomatic postmenopausal women.
P. Depriest, J. van Nagell, H. Gallion, D. Shenson +4 more
1994Gynecologic Oncology42 citations
Semantic Scholar
Does the progression‐free interval after primary chemotherapy predict survival after salvage chemotherapy in advanced and recurrent endometrial cancer?
K. Moore, C. Tian, D. S. McMeekin, J. Thigpen +2 more
2010Cancer38 citations
Semantic Scholar
Single nucleotide polypmorphisms in ERCC1 are associated with disease progression, and survival in patients with advanced stage ovarian and primary peritoneal carcinoma; a Gynecologic Oncology Group study.
T. Krivak, K. Darcy, C. Tian, M. Bookman +3 more
2011Gynecologic Oncology37 citations
Semantic Scholar
Utilizing Patient-Derived Epithelial Ovarian Cancer Tumor Organoids to Predict Carboplatin Resistance
J. Gorski, Zhu-Wei Zhang, J. R. McCorkle, J. DeJohn +6 more
2021Biomedicines36 citations Open access
Semantic Scholar
Analysis of CHEK2 gene for ovarian cancer susceptibility.
B. Baysal, J. Deloia, J. E. Willett-Brozick, M. Goodman +6 more
2004Gynecologic Oncology36 citations
Semantic Scholar
Feasibility assessment of a chemoresponse assay to predict pathologic response in neoadjuvant chemotherapy for breast cancer patients.
Zhi-Bao Mi, F. Holmes, B. Hellerstedt, J. Pippen +6 more
2008Anticancer Research35 citations
Semantic Scholar
Contribution of BRCA1 and BRCA2 to familial ovarian cancer: a gynecologic oncology group study.
Mark Reedy, H. Gallion, J. Fowler, R. Kryscio +1 more
2002Gynecologic Oncology34 citations
Semantic Scholar
Hypermethylation at a chromosome 17 "hot spot" is a common event in ovarian cancer.
M. Pieretti, D. Powell, H. Gallion, P. S. Conway +2 more
1995Human Pathology33 citations
Semantic Scholar
Next Generation Sequencing and Molecular Biomarkers in Ovarian Cancer—An Opportunity for Targeted Therapy
L. Harbin, H. Gallion, Derek B. Allison, J. Kolesar
2022Diagnostics32 citations Open access
Semantic Scholar
Molecular genetic changes in human epithelial ovarian malignancies.
H. Gallion, D. Powell, J. Morrow, M. Pieretti +5 more
199232 citations
Semantic Scholar
Images of estrogen-receptor-positive breast tumors produced by estradiol labeled with iodine I 123 at 16 alpha.
D. Kenady, E. Pavlik, K. Nelson, J. R. van Nagell +4 more
1993Archives of Surgery31 citations
Semantic Scholar
MUTYH as an Emerging Predictive Biomarker in Ovarian Cancer
M. Hutchcraft, H. Gallion, J. Kolesar
2021Diagnostics29 citations Open access
Semantic Scholar
BRCA1 germline mutations and polymorphisms in a clinic-based series of ovarian cancer cases: a Gynecologic Oncology Group study.
Simon A. Smith, W. E. Richards, Kathryn Caito, Parviz Hanjani +3 more
2001Gynecologic Oncology29 citations
Semantic Scholar
CHEMOTHERAPY INTENSITY AND TOXICITY AMONG BLACK AND WHITE WOMEN WITH ADVANCED AND RECURRENT ENDOMETRIAL CANCER: A GYNECOLOGIC ONCOLOGY GROUP STUDY
J. Farley, C. Tian, G. Rose, C. Brown +6 more
2010Cancer26 citations Open access
Semantic Scholar
Expression and activity of taxane-metabolizing enzymes in ovarian tumors.
J. Deloia, W. Zamboni, Jacqueline M. Jones, S. Strychor +2 more
2008Gynecologic Oncology23 citations
Semantic Scholar
Antisense inhibition of BRCA1 expression and molecular analysis of hereditary tumors indicate that functional inactivation of the p53 DNA damage response pathway is required for BRCA-associated tumorigenesis.
Mark Reedy, T. Hang, H. Gallion, S. Arnold +1 more
2001Gynecologic Oncology23 citations
Semantic Scholar
Immunohistochemical staining for CA-125 in fallopian tube carcinomas.
L. Puls, D. Davey, P. Depriest, H. Gallion +3 more
1993Gynecologic Oncology22 citations
Semantic Scholar
Paclitaxel and Carboplatin for Recurrent or Persistent Cancer of the Cervix
A. Sit, J. Kelley, H. Gallion, A. Kunschner +1 more
2004Cancer Investigation21 citations
Semantic Scholar
Disease-Specific Survival of Type I and Type II Epithelial Ovarian Cancers—Stage Challenges Categorical Assignments of Indolence & Aggressiveness
E. Pavlik, Christopher G. Smith, T. Dennis, E. Harvey +13 more
2020Diagnostics20 citations Open access
Semantic Scholar
THE MALIGNANT POTENTIAL OF SMALL CYSTIC OVARIAN TUMORS IN WOMEN OVER 50 YEARS OF AGE
C. Bailey, F. Ueland, G. Land, P. Depriest +3 more
199819 citations
Semantic Scholar
Localisation of the breast‐ovarian cancer susceptibility gene (BRCAI) on 17q12–21 to an interval of ⩽IcM
Simon A. Smith, R. Dicioccio, J. Struewing, D. Easton +11 more
1994Genes, Chromosomes and Cancer19 citations
Semantic Scholar
The Efficacy of Transvaginal Sonographic Screening in Asymptomatic Women at Risk for Ovarian Cancer
J. van Nagell, P. Depriest, Mark Reedy, H. Gallion +3 more
200018 citations
Semantic Scholar
Clinical Factors Associated with Longer Hospital Stay Following Ovarian Cancer Surgery
Christopher G. Smith, D. Davenport, J. Gorski, A. McDowell +10 more
2019Healthcare14 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

P. Depriest×17
Invite
P. Depriest — researcher profile on SciRah
J. van Nagell×15
Invite
J. van Nagell — researcher profile on SciRah
E. Pavlik×11
Invite
E. Pavlik — researcher profile on SciRah
R. Kryscio×11
Invite
R. Kryscio — researcher profile on SciRah

×9

Invite

F. Ueland — researcher profile on SciRah

Invite

J. Deloia — researcher profile on SciRah

Invite

J. Hunter — researcher profile on SciRah

Invite

D. Powell — researcher profile on SciRah

Invite

C. Tian — researcher profile on SciRah

Invite

M. Pieretti — researcher profile on SciRah

Invite

Mark Reedy — researcher profile on SciRah

S. J. Andrews×4

Invite

S. J. Andrews — researcher profile on SciRah